fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease - PubMed
- ️Sat Jan 01 2005
Comparative Study
fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease
Mark W Bondi et al. Neurology. 2005.
Abstract
Objective: To determine whether APOE genotype influences brain response and whether nonverbal stimuli generate findings comparable with those of previous studies that used verbal stimuli. The relationship between APOE genotype and blood oxygenation level dependent (BOLD) brain response was examined during a picture-encoding task in nondemented older adults.
Methods: Twenty nondemented participants with normal episodic memory function were divided into two groups based on the presence (n = 10) or absence (n = 10) of the APOE epsilon4 allele. Picture learning was completed during functional MRI in a blocked design alternating between experimental (novel pictures) and control (repeated picture) conditions.
Results: Nondemented older adults with an APOE epsilon4 allele showed greater magnitude and extent of BOLD brain response during learning of new pictures relative to their matched epsilon3 counterparts. Different patterns and directions of association between hippocampal activity and learning and memory performance were also demonstrated.
Conclusions: The results suggest that brain response differences are not due to poorer general memory abilities, differential atrophy, or brain response during control conditions, but instead appear to be directly influenced by APOE genotype. Results are consistent with a compensatory hypothesis wherein older adults at genetic risk for Alzheimer disease by virtue of the APOE epsilon4 allele appear to require additional cognitive effort to achieve comparable performance levels on tests of episodic memory encoding.
Figures

Magnitude and direction of brain response to the task overlaid onto axial slices of a representative anatomic image in Talairach space (slices span from 12 inferior to 54 superior in 6 mm increments). Activations shown include voxels significant at p < 0.025 that are contained within a cluster of 13 or more voxels. Color scale represents effect sizes for the within-subjects difference between conditions (ENCODE vs REPEAT) as measured by eta2 (red voxels: 0.50 < η2 ≤ 0.75; yellow voxels: 0.76 < η2 & 1.0 [η2 indexes the effect size for the magnitude of the difference between the observed response and 0]). See also table 2 for areas of significant activation. (A) APOE ε4 participants. (B) APOE ε3 participants.

Clusters of significant difference between APOE ε4 and ε3 participants for encoding-related brain response overlaid on a representative anatomic image in Talairach (1988) space (slices span from 12 inferior to 54 superior in 6 mm increments). Activations shown include voxels significant at p < 0.025 that are contained within a cluster of 13 or more voxels. Color scale represents effect sizes for the ε4 – ε3 difference in fit coefficient as measured by eta2 (signed to reflect the direction of the contrast) (red voxels: 0.50 < η2 ≤ 0.75; yellow voxels: 0.76 < η2 < 1.0).
Comment in
-
fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease.
Scarmeas N, Stern Y. Scarmeas N, et al. Neurology. 2005 Nov 8;65(9):1514-5; author reply 1514-5. doi: 10.1212/wnl.65.9.1514-a. Neurology. 2005. PMID: 16275860 No abstract available.
Similar articles
-
Wishart HA, Saykin AJ, Rabin LA, Santulli RB, Flashman LA, Guerin SJ, Mamourian AC, Belloni DR, Rhodes CH, McAllister TW. Wishart HA, et al. Am J Psychiatry. 2006 Sep;163(9):1603-10. doi: 10.1176/ajp.2006.163.9.1603. Am J Psychiatry. 2006. PMID: 16946187
-
Bangen KJ, Restom K, Liu TT, Wierenga CE, Jak AJ, Salmon DP, Bondi MW. Bangen KJ, et al. J Alzheimers Dis. 2012;31 Suppl 3(0):S59-74. doi: 10.3233/JAD-2012-120292. J Alzheimers Dis. 2012. PMID: 22531427 Free PMC article.
-
O'Hara R, Yesavage JA, Kraemer HC, Mauricio M, Friedman LF, Murphy GM Jr. O'Hara R, et al. J Am Geriatr Soc. 1998 Dec;46(12):1493-8. doi: 10.1111/j.1532-5415.1998.tb01532.x. J Am Geriatr Soc. 1998. PMID: 9848808
-
Imaging studies and APOE genotype in persons at risk for Alzheimer's disease.
Scarmeas N, Stern Y. Scarmeas N, et al. Curr Psychiatry Rep. 2006 Feb;8(1):11-7. doi: 10.1007/s11920-006-0076-1. Curr Psychiatry Rep. 2006. PMID: 16513038 Free PMC article. Review.
-
Use of functional magnetic resonance imaging in the early identification of Alzheimer's disease.
Wierenga CE, Bondi MW. Wierenga CE, et al. Neuropsychol Rev. 2007 Jun;17(2):127-43. doi: 10.1007/s11065-007-9025-y. Epub 2007 May 3. Neuropsychol Rev. 2007. PMID: 17476598 Free PMC article. Review.
Cited by
-
Trojsi F, Monsurrò MR, Esposito F, Tedeschi G. Trojsi F, et al. Neural Plast. 2012;2012:473538. doi: 10.1155/2012/473538. Epub 2012 Jun 10. Neural Plast. 2012. PMID: 22720174 Free PMC article. Review.
-
Ju S, Horien C, Shen X, Abuwarda H, Trainer A, Constable RT, Fredericks CA. Ju S, et al. Front Dement. 2023 Mar 20;2:1126016. doi: 10.3389/frdem.2023.1126016. eCollection 2023. Front Dement. 2023. PMID: 39082002 Free PMC article.
-
Lin F, Ren P, Lo RY, Chapman BP, Jacobs A, Baran TM, Porsteinsson AP, Foxe JJ; Alzheimer’s Disease Neuroimaging Initiative. Lin F, et al. J Alzheimers Dis. 2017;55(2):669-678. doi: 10.3233/JAD-160715. J Alzheimers Dis. 2017. PMID: 27716674 Free PMC article.
-
Neural correlates of subjective cognitive decline in adults at high risk for Alzheimer's disease.
Ben-Ami L, Ravona-Springer R, Tsarfaty G, Raizman R, Shumacher A, Sharvit-Ginon I, Greenbaum L, Bendlin BB, Okun E, Heymann A, Schnaider Beeri M, Livny A. Ben-Ami L, et al. Front Aging Neurosci. 2023 Feb 1;15:1067196. doi: 10.3389/fnagi.2023.1067196. eCollection 2023. Front Aging Neurosci. 2023. PMID: 36819726 Free PMC article.
-
Clark CP, Brown GG, Archibald SL, Fennema-Notestine C, Braun DR, Thomas LS, Sutherland AN, Gillin JC. Clark CP, et al. Psychiatry Res. 2006 Jan 30;146(1):43-51. doi: 10.1016/j.pscychresns.2005.09.007. Epub 2005 Dec 27. Psychiatry Res. 2006. PMID: 16380239 Free PMC article.
References
-
- Albert MS, Moss MB, Tanzi R, Jones K. Preclinical prediction of AD using neuropsychological tests. J Int Neuropsychol Soc. 2001;7:631–639. - PubMed
-
- Bäckman L, Small BJ, Fratiglioni L. Stability of the preclinical episodic memory deficit in Alzheimer's disease. Brain. 2001;124:96–102. - PubMed
-
- Bondi MW, Monsch AU, Galasko D, Butters N, Salmon DP, Delis DC. Preclinical cognitive markers of dementia of the Alzheimer type. Neuropsychology. 1994;8:374–384.
-
- Chen P, Ratcliff G, Belle SH, Cauley JA, DeKosky ST, Ganguli M. Patterns of cognitive decline in presymptomatic Alzheimer disease: a prospective community study. Arch Gen Psychiatry. 2001;58:853–858. - PubMed
-
- Fuld PA, Masur DM, Blau AD, Crystal H, Aronson MK. Object-memory evaluation for prospective detection of dementia in normal functioning elderly: predictive and normative data. J Clin Exp Neuropsychol. 1990;12:520–528. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous